Quest Diagnostics Incorporated (DGX) vs Incyte Corporation (INCY)
A side-by-side comparison of Quest Diagnostics Incorporated and Incyte Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 10, 2026. Differences are shown without an overall score or investment verdict.
DGX
Quest Diagnostics Incorporated
$237.24HealthcareDelayed quote: Aug 10, 2026, 12:24 PM EDT
INCY
Incyte Corporation
$122.34HealthcareDelayed quote: Aug 10, 2026, 12:25 PM EDT
Total return — DGX vs INCY
growth of $100 · dividends reinvested · last 10yDGX +240.1% (+13.0%/yr)INCY +35.5% (+3.1%/yr)DGX compounded faster over this window
DGX INCY
DGX vs INCY: by the numbers
- •DGX is the larger company ($26.18B vs $24.80B market cap).
- •INCY trades at the lower trailing earnings multiple (15.36 vs 25.30 P/E), one valuation lens rather than an overall verdict.
- •INCY converts more revenue to profit (27.71% vs 9.19% net margin).
- •INCY grew revenue faster over the past five years (16.43% vs 0.89% CAGR).
- •DGX pays a dividend (1.39% yield), while INCY has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | DGX | INCY |
|---|---|---|
| P/E ratio | 25.30 | 15.36 |
| Forward P/E | 21.30 | 28.83 |
| P/S ratio | 2.31 | 4.31 |
| P/B ratio | 3.55 | 3.96 |
| EV / EBITDA | 16.25 | 10.93 |
| FCF yield | 4.57% | 7.65% |
Profitability
| Metric | DGX | INCY |
|---|---|---|
| Gross margin | 33.15% | 92.62% |
| Operating margin | 14.14% | 31.57% |
| Net margin | 9.19% | 27.71% |
| ROE | 14.13% | 25.41% |
| ROIC | 8.43% | 20.58% |
Dividends
| Metric | DGX | INCY |
|---|---|---|
| Dividend yield | 1.39% | N/A |
| Payout ratio | 37.43% | N/A |
Growth (annualized)
| Metric | DGX | INCY |
|---|---|---|
| Revenue CAGR (5Y) | 0.89% | 16.43% |
| EPS CAGR (5Y) | -3.65% | 21.19% |
| FCF CAGR (5Y) | -10.89% | 33.69% |
| Total return CAGR (5Y) | 12.37% | 9.58% |
Frequently asked
- Which has the lower trailing P/E, DGX or INCY?
- INCY has the lower trailing P/E: DGX trades at 25.30 and INCY at 15.36. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, DGX or INCY?
- Over the past five years, INCY grew revenue faster — DGX at a 0.89% CAGR versus INCY at 16.43%.
- Does DGX or INCY pay a bigger dividend?
- DGX pays a dividend (1.39% yield), while INCY has no payments in the available dividend history.
- Is DGX or INCY more profitable?
- INCY runs the higher net margin — DGX at 9.19% versus INCY at 27.71%.
- How have DGX and INCY total returns compared?
- Over the past 10 years, DGX delivered 12.97% and INCY delivered 2.87% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Quest Diagnostics P/E ratioIncyte P/E ratioQuest Diagnostics dividend yieldQuest Diagnostics ROEIncyte ROEQuest Diagnostics operating marginIncyte operating marginQuest Diagnostics revenue growthIncyte revenue growthQuest Diagnostics free cash flowIncyte free cash flow
Quest Diagnostics & Incyte appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 10, 2026.